These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 36108975)
1. SARS-CoV-2 seroprevalence and antibodies persistence among health care workers after the first COVID-19 wave in nine hospitals in Western France. Garlantezec R; Tadié E; Heslan C; Gary-Bobo P; Oumari S; Saade A; Sitruk A; Tattevin P; Thibault V; Paris C; Infect Dis Now; 2022 Nov; 52(8):447-452. PubMed ID: 36108975 [TBL] [Abstract][Full Text] [Related]
2. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study. Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland. Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran. Darvishian M; Sharafkhah M; Mohammadi Z; Sadeghniiat-Haghighi K; Abdollahi A; Jafary M; Talaschian M; Tabarsi P; Baghai P; Mardani M; Shayanrad A; Shafighian F; Markarian M; Roozafzai F; Zamani M; Alvand S; Hariri S; Sadeghi A; Poustchi H; Malekzadeh R Front Public Health; 2022; 10():832003. PubMed ID: 35400056 [TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of anti-SARS-CoV-2 IgG antibodies pre- and post-COVID-19 vaccination in staff members of Bandar Abbas Children's Hospital. Tariverdi M; Mohammadi H; Hassanzadeh F; Tamaddondar M BMC Infect Dis; 2024 Feb; 24(1):253. PubMed ID: 38395759 [TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up. Recanatini C; GeurtsvanKessel CH; Pas SD; Broens EM; Maas M; van Mansfeld R; Mutsaers-van Oudheusden AJG; van Rijen M; Schippers EF; Stegeman A; Tami A; Veldkamp KE; Visser H; Voss A; Wegdam-Blans MCA; Wertheim HFL; Wever PC; Koopmans MPG; Kluytmans JAJW; Kluytmans-van den Bergh MFQ; Antimicrob Resist Infect Control; 2023 Nov; 12(1):137. PubMed ID: 38031155 [TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India. Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947 [TBL] [Abstract][Full Text] [Related]
8. Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study. Ladoire S; Rederstorff E; Goussot V; Parnalland S; Briot N; Ballot E; Truntzer C; Ayati S; Bengrine-Lefevre L; Bremaud N; Coudert B; Desmoulins I; Favier L; Fraisse C; Fumet JD; Hennequin A; Hervieu A; Ilie S; Kaderbhai C; Lagrange A; Martin N; Mazilu I; Mayeur D; Palmier R; Simonet-Lamm AL; Vincent J; Zanetta S; Arnould L; Coutant C; Bertaut A; Ghiringhelli F Eur J Cancer; 2022 Apr; 165():13-24. PubMed ID: 35189537 [TBL] [Abstract][Full Text] [Related]
9. Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study. Ocias LF; Skogstam A; Kjerstadius T; Lundin F; Tevell S Infect Dis (Lond); 2021; 53(12):920-929. PubMed ID: 34350813 [TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India. Gupta R; Dwivedi T; Gajendra S; Sahoo B; Gupta SK; Vikas H; Singh AR; Mohan A; Bhatnagar S; Singh S; Wundavalli L; Guleria R Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):207-213. PubMed ID: 33642348 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic. Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085 [No Abstract] [Full Text] [Related]
12. Seroprevalence in health care workers during the later phase of the second wave: Results of three hospitals in Serbia, prior to vaccine administration. Markovic-Denic L; Zdravkovic M; Ercegovac M; Djukic V; Nikolic V; Cujic D; Micic D; Pekmezovic T; J Infect Public Health; 2022 Jul; 15(7):739-745. PubMed ID: 35691217 [TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study. Murhekar MV; Bhatnagar T; Thangaraj JWV; Saravanakumar V; Santhosh Kumar M; Selvaraju S; Rade K; Kumar CPG; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Chopra V; Das D; Devi KR; Dwivedi GR; Jain A; Khan SMS; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Ramesh T; Rangaraju C; Turuk J; Yadav S; Bhargava B; PLoS Med; 2021 Dec; 18(12):e1003877. PubMed ID: 34890407 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area. Alroqi F; Masuadi E; Alabdan L; Nogoud M; Aljedaie M; Abu-Jaffal AS; Barhoumi T; Almasoud A; Alharbi NK; Alsaedi A; Khan M; Arabi YM; Nasr A J Infect Public Health; 2021 Sep; 14(9):1268-1273. PubMed ID: 34479078 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves. de Visscher N; Holemans X; Gillain A; Kornreich A; Lagasse R; Piette P; Ventura M; Thys F Viruses; 2022 Jul; 14(7):. PubMed ID: 35891515 [No Abstract] [Full Text] [Related]
16. High SARS-CoV-2 Prevalence among Healthcare Workers in Cochabamba, Bolivia. Saba Villarroel PM; Castro Soto MDR; Undurraga V; Sanz H; Jaldín AM; Ninove L; Nurtop E; Pezzi L; Mohamed Ali S; Amroun A; Seston M; de Lamballerie X Viruses; 2022 Jan; 14(2):. PubMed ID: 35215826 [TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts. Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668 [TBL] [Abstract][Full Text] [Related]
18. COVID-19: Hotspot hospital?- seroprevalence of SARS-CoV-2 antibodies in hospital employees in a secondary care hospital network in Germany: Intermediate results of a prospective surveillance study. Hildebrandt A; Hökelekli O; Uflacker L; Rudolf H; Gatermann SG Int J Hyg Environ Health; 2021 Jun; 235():113771. PubMed ID: 34049092 [TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of Covid-19 infection among healthcare workers: A study from a tertiary care hospital in the National Capital Region of India. Kataria S; Phogat R; Sharma P; Deswal V; Alam S; Singh M; Kumar K; Gupta V; Singh P; Dutt R; Sarma S; Saxena R; Trehan N Natl Med J India; 2022; 35(4):219-220. PubMed ID: 36715047 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark. von Huth S; Lillevang ST; Røge BT; Madsen JS; Mogensen CB; Coia JE; Möller S; Justesen US; Johansen IS Int J Infect Dis; 2021 Nov; 112():96-102. PubMed ID: 34534698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]